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Abstract
Introduction
Diarrhea is a frequent complication in hematologic patients, being an infectious cause fre-
quently suspected. Rapid and accurate detection of gastrointestinal pathogens is vital in
immunocompromised hosts. The aim of this study was to compare routine diagnostic meth-
ods versus a multiplex polymerase chain reaction (PCR) assay for the diagnosis of infec-
tious diarrhea in immunocompromised hematologic patients.
Material and methods
We conducted a prospective observational study from March 2015 to January 2016 to com-
pare conventional methods for the diagnosis of infectious diarrhea with FIlmArray GI Panel
(BioFire-bioMe´rieux, France). Samples from adult immunocompromised hematologic
patients with acute diarrhea were collected. In cases with discordant results, a second multi-
plex assay was performed (Allplex, Seegene, Korea). The result was considered positive or
negative when the same result was obtained by at least two of the methods.
Results
A total of 95 samples were obtained from 95 patients (median age of 52 years (46–64)).
Sixty-one (64%) episodes were hospital-acquired and 34 (36%) were community-acquired
diarrhea. Twenty-five (26%) patients had a positive microbiological result, being Clostridium
difficile the most frequent pathogen, followed by Campylobacter spp and norovirus. The
concordance between FilmArray methods was good (k = 0.79). The FilmArray GI panel
showed a sensitivity of 95%, a specificity of 100% for positive results. The time required to
obtain results was markedly reduced with the use of multiplex PCR methods.
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Conclusions
Multiplex molecular panels provide a rapid and sensitive tool for the diagnosis of infectious
diarrhea, thereby allowing more timely clinical decisions in immunocompromised hemato-
logic patients.
Introduction
Diarrhea is a very frequent complication in immunocompromised patients, including hemato-
logic patients. In patients with these underlying conditions diarrhea can be a severe disease,
affecting the patient’s quality of life and leading to longer hospitalizations.
Diarrhea can be caused by many different community- and hospital-acquired pathogens,
including several bacteria, viruses and, less frequently, parasites. However, the etiology of diar-
rhea in these patients may be multiple, varying from infectious disease, graft-versus-host disease
or drug-induced diarrhea [1]. Even though diarrhea in hematologic patients is a frequent and
important issue, there is a lack of studies regarding the etiology of diarrhea in these patients.
Rapid accurate diagnosis of the etiology of diarrhea is required in order to implement the
most adequate treatment in immunocompromised patients. Conventional diagnostic tech-
niques, such as culture, microscopy and antigen detection, as well as one-target polymerase
chain reaction (PCR) assays, are often laborious and time-consuming, and are only able to
detect a limited number of pathogens. Taking these limitations into account faster and more
sensitive molecular tests able to simultaneously detect a wide range of bacterial, viral and para-
sitic pathogens might be helpful in the case of these patients. Several studies have evaluated
these assays in various settings, but their performance in hematological patients has yet to be
determined [2][3]. The FilmArray GI panel (BioFire-bioMe´rieux, France) is a FDA-cleared
assay that can detect 22 agents of gastroenteritis by a nested multiplex PCR method directly
from stool samples, being a very rapid and easy-to-use technique.
The aim of this study was to compare routine diagnostic methods with a multiplex PCR
assay (BioFire FilmArray, Gastrointestinal Panel) and to determine the infectious etiology of
acute diarrhea in immunocompromised hematologic patients.
Material and methods
Study design
This was a prospective observational study carried out from between March 2015 to January
2016. Stool samples were obtained from immunocompromised adult patients (>18 years-old)
admitted to the Hematology Department of the Hospital Clinic of Barcelona with acute diar-
rhea (increased frequency of soft or liquid stools (>3/day) lasting less than 14 days) [4]. Writ-
ten consent was not obtained from the patients, as the samples were remmants of what had to
be taken for other diagnostic purposes and the results would have no impact on the patients.
The Ethics Committee of the Hospital Clinic of Barcelona approved the study.
Immunosupression was defined as grades 3–4 neutropenia and/or lymphopenia by the
National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0 following the
administration of cytotoxic agents or autologous stem-cell transplantation (auto-SCT) or dur-
ing the first year after allogenic stem-cell transplantation (allo-SCT) [5].
Demographical data including age and sex, and clinical data (community or hospital-
acquired diarrhea (acquired >72 hours after admission [4]), diagnosis of graft-versus-host dis-
ease, underlying conditions) were obtained from the patients’ clinical history.
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A single stool sample was obtained from each patient. The fresh stool specimens were
immediately inoculated into different bacterial culture media. The remainder of the sample
was stored at 4˚C. The remaining routine tests and FilmArray GI Panel were performed only
during working hours (i.e. from 8am to 3pm from Monday to Friday). An aliquot of each sam-
ple was stored at -20˚C for further studies. The maximum time from arrival of the sample until
performance of all test was 72 hours. Time and temperature affect especially culture-based pro-
cedures, which were performed at the time the sample arrived, so the storage of the samples
for further studies should not have an impact on the results of the remaining techniques.
All samples were processed by both routine methods and the FilmArray GI panel. Samples
showing a discordant result were tested by an additional method (Allplex (Seegene, Korea)).
Routine microbiological techniques
All the samples were processed for bacterial, parasitological, viral and C. difficile toxin study.
The media used for culture of bacteria were as follows: Blood and MacConkey agar plates,
SS agar plate (Becton Dickinson, Heidelberg, Germany) for Shigella and Salmonella, CIN agar
plate (Oxoid, Basingstoke, UK) for Yersinia and CCDA agar plate (Oxoid) for Campylobacter
isolation. Additionally, Rappaport-Vassiliadis Salmonella Enrichment Broth (VWK Chemi-
cals, MerckKGaA, Darmstadt, Germany) was used as an enrichment step for the recovery of
Salmonella, followed by plating onto SS agar. All of the plates were incubated at 37˚C a 5%
CO2 atmosphere for 24–48 hours, except for Campylobacter agar which was incubated in a
microaerophilic environment at 42˚C.
The final identification of the bacterial isolates was performed by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF (Bruker, Bremen, Ger-
many)). The presence or absence of diarrheagenic Escherichia coli was not studied by routine
methods in these patients.
Clostridium difficile diarrhea was detected following a two-step scheme: detection of GDH
by immunochromatography (Health&Research Diagnostics, Spain), followed by PCR (Xpert
C. difficile, Cepheid, California) in the case of a GDH-positive result.
Parasites were detected by microscopy of both, direct and concentrated samples (merthoi-
late formalin ether method). Modified Kinyoun acid-fast stain was also performed to diagnose
Cryptosporidium and Cyclospora cayetanensis.
The detection of viruses was performed using immunochromatographic tests for rotavirus
and adenovirus antigens (VIKIA Rota-adeno, bioMe´rieux, France) and a real time RT-PCR
for detection of norovirus (Xpert Norovirus, Cepheid, California).
Data regarding the time from sample arrival to the laboratory until definitive identification
by routine techniques was also obtained. Fresh stool samples were immediately inoculated
into different media upon arrival of the samples to the laboratory, but the reading of the plates,
microscopic examination, immunochromatographic tests and PCR techniques were only per-
formed during working hours (i.e. from 8am to 3pm from Monday to Friday).
FilmArray
The FilmArray GI Panel is an automated system in which nucleic acid extraction, amplifica-
tion and detection occur on a single closed pouch. A nested PCR and melt-curve analysis are
performed and analyzed by the FilmArray analyzer. The amount of sample needed is very
small and it has a hands-on time of approximately 5 minutes. The total turnaround time is
about 1 hour.
All the samples were also processed by the FilmArray GI panel (BioFire-bioMe´rieux,
France) following the manufacturer’s instructions. The FilmArray GI Panel was only
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performed during working hours. However, clinicians were not informed of the results
obtained with this method, and therefore they had not an impact on patient management.
This panel includes a total of 22 targets, including bacteria (Campylobacter jejuni, Campylobac-
ter coli, Campylobacter upsaliensis, Clostridium difficile (toxin A/B), Plesiomonas shigelloides,
Salmonella, Yersinia enterocolitica, Vibrio parahaemolyticus, Vibrio vulnificus, Vibrio cholerae
and diarrheagenic Escherichia coli/Shigella (Enteroaggregative E. coli (EAEC), Enteropatho-
genic E. coli (EPEC), Enterotoxigenic E. coli (ETEC) lt/st, Shiga-like toxin-producing E. coli
(STEC) stx1/stx-2, E. coli O157, Shigella/Enteroinvasive E. coli (EIEC)), parasites (Cryptospo-
ridium, Cyclospora cayetanensis, Entamoeba histolytica, Giardia lamblia) and viruses (Adenovi-
rus F 40/41, Astrovirus, norovirus GI/GII, Rotavirus A, Sapovirus (I, II, IV and V)). The
detection methods used for each of the pathogens are further explained in the panel insert
(https://www.online-ifu.com/ITI0030).
Confirmation testing
Discordant results between routine methods and the FilmArray GI Panel were confirmed
using a second multiplex PCR panel, Allplex (Seegene, Korea), following the manufacturer’s
instructions. This assay is made up of 4 different panels that include the following: Panel 1
Virus (Norovirus GI and GII, Rotavirus, Adenovirus, Astrovirus, and Sapovirus), Panel 2 Bac-
teria I (Campylobacter spp, Clostridium difficile toxin B, Salmonella spp, EIEC/Shigella spp, Vib-
rio spp, Yersinia enterocolitica, Aeromonas spp), Panel 3 Bacteria II (Clostridium difficile
hypervirulent, E. coli O157, EHEC, EPEC, ETEC, and EAEC) and Panel 4 Parasite (Giardia
lamblia, Entamoeba histolytica, Cryptosporidium spp, Blastocystis hominis, Dientamoeba fragilis,
and Cyclospora cayetanensis).
The stool specimen was previously shaken in a bead tube with lysis buffer and then centri-
fuged. Then 200 μl of the supernatant were used for automatic extraction with the EZ1 Virus
Mini Kit (Qiagen), obtaining the nucleic acids in 60 μl of AVE elution buffer.
Result interpretation
A result was considered positive or negative when the same result was obtained by at least two
of the three methods.
Statistical analysis
We show the number and percentage of patients for categorical variables and the median
(interquartile range) for continuous variables. The Cohen’s kappa coefficient (k) [6] was calcu-
lated to measure the agreement between the FilmArray GI Panel and the routine methods. The
sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and
likelihood ratios (LR) of positive detection of the FilmArray GI Panel and routine methods
were also calculated for comparison with the final diagnosis. All tests were 2-tailed and signifi-
cance was set at 0.005. All analyses were performed with IBM SPSS Statistics 22.0 (Armonk,
New York, USA) and Epidat 3.1 (Santiago de Compostela, A Coruña, Spain).
Ethical aspects
This study was approved by the Ethics Committee of the Hospital Clinic of Barcelona, which
considered that written consent was not necessary, as the samples had to be taken for other
diagnostic purposes and the results had no impact on the patients.
BioMerieux España S.A.U. provided the kits of FilmArray used in this study. They did not,
however, take part in designing the study or in analyzing the results.
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Results
Patients and samples
During the study period, a total of 95 stool samples were obtained from 95 patients with a
median age of 52 years (46–64). Forty-one (43%) patients were within the first year after an
allo-SCT, and the remaining patients were immunocompromised after an auto-SCT (n = 19;
20%) or secondary to chemotherapy for acute leukemia (n = 19; 20%), lymphoma (n = 9;
10%), multiple myeloma (n = 3; 3%), myelodysplastic syndrome (n = 2; 2%) or other underly-
ing immunosuppressive conditions (n = 2; 2%). Graft-versus-host disease was suspected in 5
patients with allogenic bone marrow transplantation, but it was confirmed in only two of these
patients.
Regarding the acquisition of diarrhea, 61 episodes were classified as nosocomial diarrhea
(64%) and 34 were community-acquired diarrhea (36%).
Laboratory results
A positive definite diagnosis was achieved in 25 patients (26%), with the same pathogen being
detected in at least two of the three methods tested. Table 1 shows the positive results obtained
with all the methods and the final interpretation of them. The percentage of positive samples
excluding those with only diarrheagenic E.coli was 22%.
A total of 70 samples were negative by both methods, ruling out infectious etiology in this
group of patients.
Diarrheagenic E. coli were detected by the FilmArray GI Panel, but these pathogens were
not searched for by routine methods. Diarrheagenic E.coli were detected in 12 samples using
the Filmarray GI Panel, 10 of which were confirmed by Allplex. E. coli was the only pathogen
detected in 4 of these samples.
Excluding diarrheagenic E. coli, the most frequent etiological agent was C. difficile, being
identified in 10 samples (in two samples the immunochromatographic test was negative, and
thus PCR was not performed, leading to routine methods not detecting C. difficile). The second
most frequent pathogen was Campylobacter spp, being detected in 6 samples (not detected by
culture techniques in 2 cases). The third most frequent pathogen was norovirus which was
detected in 5 cases. Other less frequent etiologies were salmonella, adenovirus, rotavirus and
giardia. Table 2 shows the frequency of the pathogens detected in total, by each method, their
frequency in coinfection and the type of acquisition.
In 15 samples only one pathogen was found, whereas 10 patients presented coinfections (9
coinfections with 2 pathogens and 1 coinfection with 3 pathogens).
Among the samples with a positive microbiologic result, there were 10 hospital-acquired
(40%) and 15 community-acquired diarrhea (60%). In the 10 cases of nosocomial diarrhea the
most frequent pathogen was also C. difficile in 5 cases (50%) followed by norovirus in 3 (30%).
The concordance between the FilmArray GI Panel and routine methods was good
(k = 0.79, 95% CI [0.65 to 0.91], p<0.001). The positive results obtained using the FilmArray
GI Panel had a sensitivity of 95%, a specificity of 100%, a PPV of 100%, a NPV of 99%, a LR+
of 140 and a LR- of 0.05, being 75%, 99%, 94%, 94%, 57 and 0.25, respectively with routine
methods (Table 3). As mentioned previously, routine methods did not take diarrheagenic E.
coli into account.
Regarding the time to achieving the results, the routine methods took up to 89 hours (53–
110) for a definite result.
The samples from all 5 patients with suspected graft-versus-host disease were negative with
both the routine methods and the FilmArray GI Panel.
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Discussion
The etiology of the diarrhea in our cohort of immunocompromised hematologic patients was
infectious in 26% of the cases. This percentage of infectious diarrhea is similar to that reported
in previous studies focusing in other populations of immunocompromised patients [7] and
highlights the importance of an infectious etiology in this group of patients.
The most frequently detected pathogen was C. difficile which is in agreement with previous
studies [8][9], showing that this etiology of diarrhea should be taken into account in these
patients, especially if they have been hospitalized for a prolonged period of time. However,
even though until recently this pathogen was considered a nosocomial pathogen, we found
that half of our cases were not hospital-acquired. Again, this is in agreement with a popula-
tion-based study that found that 41% of C. difficile infections were community-acquired [10].
In view of the present data, the lack of previous hospitalization or contact with other health
Table 1. Microbiological results obtained by each method and the final diagnosis of the positive cases.
Patient Diagnostic methods Final Diagnosis
FilmArray Routine Allplex
7 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
12 Campylobacter spp Campylobacter jejuni NA Campylobacter spp
18 Rotavirus Rotavirus NA Rotavirus
20 Campylobacter spp + Clostridium
difficile toxin A/B
Campylobacter jejuni + Clostridium
difficile toxin A/B
NA Campylobacter spp + Clostridium
difficile toxin A/B
21 EPEC + Clostridium difficile toxin A/
B
Negative EPEC + Clostridium difficile
toxin A/B
EPEC + Clostridium difficile toxin A/
B
23 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
24 EPEC + ETEC Negative EPEC + ETEC EPEC + ETEC
27 EPEC Negative EPEC EPEC
28 EPEC Negative EPEC EPEC
44 EPEC + Norovirus Adenovirus + Norovirus EPEC + Norovirus EPEC + Norovirus
47 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
48 EPEC Negative Negative Negative
55 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
56 Norovirus Norovirus NA Norovirus
58 ETEC + EPEC Adenovirus ETEC + Adenovirus ETEC + Adenovirus
60 EAEC + Campylobacter spp Negative EAEC + Campylobacter spp EAEC + Campylobacter spp
70 EPEC Negative Negative Negative
73 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
76 Campylobacter spp + EPEC Campylobacter jejuni Campylobacter spp + EPEC Campylobacter spp + EPEC
79 Campylobacter spp Negative Campylobacter spp Campylobacter spp
84 Salmonella spp + EPEC
+ Norovirus
Salmonella typhimurium + Norovirus Salmonella spp + EPEC
+ Norovirus
Salmonella spp + EPEC
+ Norovirus
85 Norovirus Norovirus NA Norovirus
86 Campylobacter spp + Giardia
lamblia
Campylobacter jejuni Campylobacter spp + Giardia
lamblia
Campylobacter spp + Giardia
lamblia
90 Clostridium difficile toxin A/B
+ Norovirus
Norovirus Clostridium difficile toxin A/B
+ Norovirus
Clostridium difficile toxin A/B
+ Norovirus
92 EPEC Negative EPEC EPEC
97 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
100 Clostridium difficile toxin A/B Clostridium difficile toxin A/B NA Clostridium difficile toxin A/B
Abbreviations: EAEC Enteroaggregative E. coli, EPEC Enteropathogenic E. coli, ETEC Enterotoxigenic E. coli lt/st, NA not applicable
https://doi.org/10.1371/journal.pone.0187458.t001
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care settings should not exclude the suspicion of C. difficile diarrhea. However, the classifica-
tion of episodes of diarrhea as hospital- or community-acquired in immunocompromised
patients is not easy, since these patients are frequently in contact with the health care system
and often require hospitalization. In addition, according to our algorithm, two cases were not
detected because of a negative GDH result. When The FilmArray results were available, these
samples were re-tested by RT-PCR and positive results were obtained. This shows that our
diagnostic algorithm could miss cases with false negative immunochromatography results
which would not remain unnoticed with the FilmArray GI Panel.
Campylobacter were the second most frequently detected bacteria in our study. In 2 out of
the 6 cases, the microorganism was not isolated in the culture. The lack of sensitivity of culture
techniques for Campylobacter has been reported previously [11], although this has improved
greatly with the new molecular techniques.
The most frequent viral pathogen was Norovirus. Several studies have reported that immu-
nosupressed patients seem to be more prone to norovirus infection than other patients [12].
This pathogen is also considered an important cause of nosocomial diarrhea, although we
found that nearly half of our cases were community-acquired.
Table 2. Summary of the pathogens detected by routine methods and FilmArray, the percentage of coinfection and the acquisition.
Pathogen Total (%) Coinfection (%) Detected by routine Detected by FilmArray Acquisition
Nosocomial Community
Bacteria
C. difficile 10 (27.78) 3 (30) 8 10 5 5
Campylobacter spp 6 (16.67) 4 (66.67) 4 6 2 4
Salmonella spp 1 (2.78) 1 (100) 1 1 1
EAEC 1 (2.78) 1 (100) NA 1 1
EPEC 8 (22.22) 5 (62.5) NA 11 1 7
ETEC 2 (5.56) 2 (100) NA 2 1 1
Virus
Adenovirus 1 (2.78) 1 (100) 1 0 1
Norovirus 5 (13.89) 3 (60) 5 5 3 2
Rotavirus 1 (2.78) 0 1 1 1
Parasites
G. lamblia 1 (2.78) 1 (100) 0 1 1
Abbreviations: EAEC Enteroaggregative E. coli, EPEC Enteropathogenic E. coli, ETEC Enterotoxigenic E. coli lt/st
https://doi.org/10.1371/journal.pone.0187458.t002
Table 3. Diagnostic accuracy of positive detection of FilmArray and Routine methods.
Results FilmArray Routine methods
Value 95% CI Value 95% CI
Sensitivity (%) 95.2 83.8 to 100.0 75.0 53.5 to 96.5
Specificity (%) 100.0 99.3 to 100.0 98.7 95.5 to 100.0
PPV (%) 100.0 97.5 to 100.0 93.8 78.8 to 100.0
NPV (%) 98.7 95.4 to 100.0 93.8 87.8 to 99.7
LR+ 140.0a 8.8 to 2219.0a 57.0 8.0 to 406.0
LR- 0.05 0.01 to 0.32 0.25 0.12 to 0.54
Abbreviations: CI confidence interval; LR, likelihood ratio; NPV, negative predictive value; PPV, positive predictive value.
a 0.5 added to cells to estimate LR+ and CI’s of the LR+.
https://doi.org/10.1371/journal.pone.0187458.t003
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An interesting finding of this study is the high number of diarrheagenic E. coli detected (10
cases, being the only pathogen found in 4), suggesting the involvement of this microorganism
as a cause of diarrhea in immunocompromised patients. These pathogens have also been
described in diarrhea in other settings, such as travelers returning from developing countries
[13]. Several studies have also described the importance of diarrheagenic E. coli as a causative
agent of diarrhea in children in developed countries[14]. Indeed, the use of multiplex panels
for the etiologic study of diarrhea has shown that this previously unsuspected pathogen is pres-
ent in many patients’ stool samples [15][16]. However, further studies are needed to analyze
the role of these pathogens in immunocompromised hematologic patients. In our study EPEC
was the most frequent diarrheagenic E. coli detected. Some studies have shown that this patho-
gen is frequently found in asymptomatic patients and healthy carriers [17][18], thereby under-
lining the importance of detecting this pathogen in these patients.
In 70 patients, who were also immunocompromised patients admitted to the Hematology
Department with acute diarrhea, negative results were obtained by both methods, ruling out
infectious diarrhea. This is also an important finding, as it would allow the clinician to con-
sider other possible non-infectious etiologies (such as drug-induced diarrhea or graft-versus-
host disease) which are frequent in these patients.
Regarding the diagnostic methods evaluated in this study, the FilmArray GI Panel showed
good concordance with the routine methods and increased sensitivity compared with these lat-
ter methods. The FilmArray GI Panel also allowed the diagnosis of unsuspected pathogens
such as diarrheagenic E. coli or even parasites and improved the number of coinfections
detected.
The ease of use of the FilmArray GI Panel allows non-trained personal to perform the anal-
ysis 24 hours a day, 7 days a week providing results in less than one hour, compared to the lon-
ger time-to-results obtained with routine methodology. The speed in obtaining results using
multiplex testing is important not only when positive results are obtained, but also in order to
rule out an infectious etiology after performing a sensitive test that includes the most frequent
pathogens. A negative result in immunocompromised hematologic patients would suggest
that the episode could be due to non-infectious causes such as immunosuppressive drugs or
graft-versus-host disease. On the other hand, a rapid diagnostic tool can have a great impact
on the control of nosocomial infections allowing the implementation of timely measures to
prevent the spread of intection and avoid the development of new cases.
Multiplex assays do, however, present some limitations. Many bacterial infections require
bacterial culture, as isolation is needed in order to perform susceptibility testing. In addition, a
higher sensitivity could imply an increase in the detection of non-viable pathogens or patho-
gens that are actually colonizers without causing infection [19]. Moreover, the FilmArray GI
Panel represents a considerable increase in cost over routine techniques. However, evaluation
of cost-effectiveness should be further studied [20], taking into account not only reagents, but
also technician time, as weel as instrumentations and hospital-associated fees (e.g. isolation
days and treatment decisions). Indeed, targeted use of the FilmArray GI Panel in specific pop-
ulations could have an impact on treatment costs and also on costs derived from nosocomial
outbreaks.
This study presents some limitations including the reduced number of patients and that its
descriptive nature which has no impact on patient management. However, the results of this
study showed that infectious agents cause a considerable number of diarrheal episodes in
immunosupressed hematological patients. These patients are a critical population that could
benefit from a rapid and sensitive diagnosis in which the confirmation of a positive result is as
important as ruling it out, since the treatment may substantially differ. The use of multiplex
PCRs may significantly reduce the time between sample reception and result reporting to the
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clinicians, and it may help them to correctly classify the cause of the diarrhea and implement
the most adequate therapy. A positive result could allow the immediate start of antibiotic ther-
apy, which could be later adjusted after antimicrobial susceptibility testing is performed by
other methods. A negative result could reduce the amount of antibiotics prescribed, improving
patient management and reducing the appearance of new resistant bacteria. However, this was
only an observational study and these aspects were not evaluated, needing further studies to
correctly assess the effectiveness of these new diagnostic approaches.
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